AcuityMD Secures $45M in Series B Funding to Expand its Commercial Intelligence Platform to Medical Technology Manufacturers
June 4, 2024
AcuityMD today announced $45 million in new funding to expand its commercial intelligence platform and advance the company’s mission of accelerating adoption of cutting-edge medical technology (MedTech).
BOSTON — June 4, 2024 — AcuityMD today announced $45 million in new funding to expand its commercial intelligence platform and advance the company’s mission of accelerating adoption of cutting-edge medical technology (MedTech). The Series B round was led by ICONIQ Growth, with additional participation from Boston-based Atreides Management and New York-based Stepstone Group as well as existing investors Redpoint Ventures, Benchmark Capital, and Artisanal Ventures. To date, AcuityMD has raised more than $83 million and achieved a significant 10x increase in annual recurring revenue since its 2022 Series A raise.
ICONIQ Growth has been the leading investor in the Forbes Cloud 100 since its inception, investing in companies such as Snowflake, Datadog, and GitLab, as well as leading vertical software companies including Procore, ServiceTitan, Benchling, QGenda, and Komodo Health. The company also has a healthcare advisory council that includes top executives from Johnson & Johnson, Stanford Healthcare, and Cleveland Clinic.
“AcuityMD is a market leader in commercial MedTech software with powerful data and prospecting insights that have elicited positive feedback from customers,” said Tengbo Li, Partner at ICONIQ Growth. “AcuityMD’s innovative platform is reminiscent of other transformative, vertical-specific platforms that we have supported. We believe that there are also exciting opportunities to extend into other product areas and expand the value proposition, and ultimately for MedTech companies to use AcuityMD as their complete commercial operating system.”
Notably, four AcuityMD investors are former MedTech CEOs, including Bill Hawkins, former CEO of Medtronic. “I’m acutely aware of the unique challenges MedTech companies face when bringing products to market,” said Hawkins. “AcuityMD has built an industry-specific platform that alleviates common pain points to help bring new treatments to patients faster. I am thrilled to be partnering with AcuityMD as it enters its next phase of growth.”
Since its founding in 2019, AcuityMD has experienced rapid growth, now supporting more than 200 MedTech manufacturers – including six of the top 10 – with its commercial intelligence platform. AcuityMD is also ranked in the top quartile of B2B software companies in customer retention and growth based on analysis from ICONIQ Growth’s “Topline Growth & Operational Efficiency” study.
AcuityMD’s commercial platform translates large volumes of healthcare data, such as physician procedural volumes, product preferences, sites of care affiliations, peer networks, and referral patterns into intuitive workflows and recommendations that align with the MedTech industry’s unique commercial process. It has resulted in more than 25% sales growth for top active sales reps and over $10 billion in opportunity pipeline created.
“We are fortunate to work with fantastic financial partners as well as experienced MedTech industry executives who broaden the perspective of our Customer Advisory Board,” said Michael Monovoukas, CEO and co-founder of AcuityMD. “With this additional capital, we aim to launch three new products to general availability, expand our pipeline management solution to more customers, and grow our engineering and product teams by 70% by the end of 2024 to support our mission of accelerating the adoption of cutting-edge medical technology.”
AcuityMD continues to grow even in a cooling market, where Series B deal sizes peaked in 2021 with $46M, followed by a steep decline that hit its lowest point of $30M average in Q4 2023. The average investment is slowly increasing again, with an average of $38.9M in January 2024 – still $5 million less than AcuityMD’s latest raise.
In other news today, AcuityMD announced that its platform is being leveraged by six of the top 10 global MedTech companies.
About ICONIQ Growth
ICONIQ Growth partners with visionaries defining the future of their industries to transform the world. Our investment platform and unique ecosystem helps amplify our portfolio companies’ success from early growth stage to IPO and beyond. Our portfolio includes Adyen, AirBnB, Alibaba, Alteryx, Automattic, BambooHR, Braze, Chime, Collibra, Coupa, Datadog, Docusign, Gitlab, Marqeta, Miro, Procore, Red Ventures, Relativity, ServiceTitan, Snowflake, Sprinklr, Truckstop, Uber, Wolt, and Zoom, among others. For more information, please visit ICONIQGrowth.com.
About AcuityMD
AcuityMD is a leading technology partner to the commercial MedTech industry. Over 200 companies use AcuityMD’s commercial platform to identify target markets, surface top opportunities, and grow their business. With customers ranging from pre-commercial to enterprise, AcuityMD is committed to providing MedTech companies with unparalleled visibility to accelerate adoption of cutting-edge medical technology. For more information, visit acuitymd.com.
Media Contact:
Lisa Barbadora, BarbadoraINK for AcuityMD
+1 (610) 420-3413
lbarbadora@barbadoraink.com
Integrate your CRM with other tools
Venenatis sollicitudin posuere elit consequat et enim. Neque tortor amet dictum tempor. Leo facilisis aliquet viverra scelerisque eleifend viverra est. At massa erat vel amet enim laoreet dictum pellentesque. Urna cursus quam pulvinar tellus. Duis fermentum nibh volutpat morbi. Et ac sed ultricies ut nunc.
How to connect your integrations to your CRM platform?
Et urna ac et maecenas fusce amet. Nibh nec commodo massa sed. Tincidunt porttitor in pharetra egestas sit neque ac lacus. Amet a nunc et cum. Odio at volutpat volutpat in leo eget ipsum diam elementum. Erat magna arcu orci.
- Morbi fringilla molestie magna sed dictum. Praesent pharetra.
- Cras mi purus, viverra vitae felis sit amet, tincidunt fringilla lorem.
- Non mattis urna ex nec sem. Donec varius diam et suscipit.
- Quisque euismod posuere lacus sit amet volutpat praesent.
Quis faucibus massa sit egestas. Sit fermentum est ac pulvinar et sagittis sed sit ut. Quis faucibus aenean nibh vestibulum enim mi sit. Sollicitudin ultrices ultrices in ipsum urna fringilla massa leo. Sapien ultricies vitae rhoncus molestie purus. Urna urna dolor euismod porttitor et. Magna adipiscing dictum et adipiscing.
Quis faucibus massa sit egestas. Sit fermentum est ac pulvinar et sagittis sed sit ut. Quis faucibus aenean nibh vestibulum enim mi sit. Sollicitudin ultrices ultrices in ipsum urna fringilla massa leo. Sapien ultricies vitae rhoncus molestie purus.
Infotech is the next-gen CRM platform designed for modern sales teams
Cursus curabitur euismod vel fermentum sapien non dolor odio vel. Tortor lectus mauris in praesent a tincidunt nam. In aenean odio aliquet pretium viverra elit quis magna. Eget ut risus posuere velit purus nisi nec sollicitudin tellus enim.
“Sed id mi eget urna facilisis pharetra. Nunc viverra est at magna maximus consectetur. Sed nec maximus augue. Aliquam commodo sem eu.”
Cursus curabitur euismod vel fermentum sapien non dolor odio vel. Tortor lectus mauris in praesent a tincidunt nam. In aenean odio aliquet pretium viverra elit quis magna. Eget ut risus posuere velit purus nisi nec sollicitudin. Tellus enim interdum neque sit vestibulum lacus. Nam pulvinar a lectus justo aliquet.
Why using the right CRM can make your team close more sales?
Sed non quis tellus velit orci. Quam sed mauris elementum tempor viverra. Luctus semper risus ipsum id diam praesent. Pretium eget mauris ultrices curabitur sed sem amet. Erat nulla habitant in mattis massa mi adipiscing.
- Morbi fringilla molestie magna sed dictum. Praesent pharetra.
- Cras mi purus, viverra vitae felis sit amet, tincidunt fringilla lorem.
- Non mattis urna ex nec sem. Donec varius diam et suscipit.
- Quisque euismod posuere lacus sit amet volutpat praesent.
What other features would you like to see in our product?
Sed non quis tellus velit orci. Quam sed mauris elementum tempor viverra. Luctus semper risus ipsum id diam praesent. Pretium eget mauris ultrices curabitur sed sem amet. Erat nulla habitant in mattis massa mi adipiscing ullamcorper condimentum. Erat quisque integer tincidunt ac amet.